Hypopharyngeal cancer secondary prevention: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}} {{AE}} {{G.D.}}, {{Faizan}} | {{CMG}} {{AE}} {{G.D.}}, {{Faizan}} | ||
==Overview== | ==Overview== | ||
Secondary [[prevention]] measures of hypopharyngeal cancer include routine [[physical]] [[examination]] and imaging at scheduled intervals after treatment. [[Dental]] and [[thyroid]] [[screenings]] for [[cancers]] are recommended among the patients who had received [[radiation therapy]] to the [[oral]] [[cavity]] and [[cervical]] regions. | Secondary [[prevention]] measures of hypopharyngeal cancer include routine [[physical]] [[examination]] and imaging at scheduled intervals after treatment. [[Dental]] and [[thyroid]] [[Screening|screenings]] for [[cancers]] are recommended among the patients who had received [[radiation therapy]] to the [[oral]] [[cavity]] and [[cervical]] regions. | ||
==Secondary Prevention== | ==Secondary Prevention== | ||
| Line 9: | Line 9: | ||
Patients treated for hypopharyngeal carcinoma should follow-up for a secondary [[prevention]]. Follow-up measures are shown in the table below:<ref name="pmid23946171">{{cite journal| author=Pfister DG, Ang KK, Brizel DM, Burtness BA, Busse PM, Caudell JJ et al.| title=Head and neck cancers, version 2.2013. Featured updates to the NCCN guidelines. | journal=J Natl Compr Canc Netw | year= 2013 | volume= 11 | issue= 8 | pages= 917-23 | pmid=23946171 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23946171 }} </ref> | Patients treated for hypopharyngeal carcinoma should follow-up for a secondary [[prevention]]. Follow-up measures are shown in the table below:<ref name="pmid23946171">{{cite journal| author=Pfister DG, Ang KK, Brizel DM, Burtness BA, Busse PM, Caudell JJ et al.| title=Head and neck cancers, version 2.2013. Featured updates to the NCCN guidelines. | journal=J Natl Compr Canc Netw | year= 2013 | volume= 11 | issue= 8 | pages= 917-23 | pmid=23946171 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23946171 }} </ref> | ||
{| style="border: 0px; font-size: 90%; margin: 3px; width: 600px" align=center | {| style="border: 0px; font-size: 90%; margin: 3px; width: 600px" align="center" | ||
|valign=top| | | valign="top" | | ||
|+ | |+ | ||
! style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF|Follow up}} | ! style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF|Follow up}} | ||
Revision as of 17:32, 23 January 2019
|
Hypopharyngeal cancer Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Hypopharyngeal cancer secondary prevention On the Web |
|
American Roentgen Ray Society Images of Hypopharyngeal cancer secondary prevention |
|
Risk calculators and risk factors for Hypopharyngeal cancer secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Gertrude Djouka, M.D.[2], Faizan Sheraz, M.D. [3]
Overview
Secondary prevention measures of hypopharyngeal cancer include routine physical examination and imaging at scheduled intervals after treatment. Dental and thyroid screenings for cancers are recommended among the patients who had received radiation therapy to the oral cavity and cervical regions.
Secondary Prevention
Follow up after treatment
Patients treated for hypopharyngeal carcinoma should follow-up for a secondary prevention. Follow-up measures are shown in the table below:[1]
| Follow up | Description |
|---|---|
|
|
|
|
|
|
|
|
|
|
References
- ↑ Pfister DG, Ang KK, Brizel DM, Burtness BA, Busse PM, Caudell JJ; et al. (2013). "Head and neck cancers, version 2.2013. Featured updates to the NCCN guidelines". J Natl Compr Canc Netw. 11 (8): 917–23. PMID 23946171.